Jade Biosciences/$JBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jade Biosciences
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Ticker
$JBIO
Sector
Primary listing
Employees
55
Headquarters
Website
Jade Biosciences Metrics
BasicAdvanced
$686M
-
-$3.19
-
$2.40
17.24%
Price and volume
Market cap
$686M
52-week high
$17.71
52-week low
$6.57
Average daily volume
282K
Dividend rate
$2.40
Financial strength
Current ratio
21.091
Quick ratio
20.325
Long term debt to equity
0.218
Total debt to equity
0.218
Interest coverage (TTM)
-31.54%
Profitability
EBITDA (TTM)
-113.516
Effective tax rate (TTM)
-0.05%
Management effectiveness
Return on assets (TTM)
-33.59%
Return on equity (TTM)
-89.18%
Valuation
Price to book
2.06
Price to tangible book (TTM)
2.06
Price to free cash flow (TTM)
-4.601
Free cash flow yield (TTM)
-21.74%
Free cash flow per share (TTM)
-3.026
Dividend yield (TTM)
17.24%
Growth
Earnings per share change (TTM)
-89.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jade Biosciences stock?
Jade Biosciences (JBIO) has a market cap of $686M as of March 16, 2026.
What is the P/E ratio for Jade Biosciences stock?
The price to earnings (P/E) ratio for Jade Biosciences (JBIO) stock is 0 as of March 16, 2026.
Does Jade Biosciences stock pay dividends?
Yes, the Jade Biosciences (JBIO) stock pays dividends to shareholders. As of March 16, 2026, the dividend rate is $2.4 and the yield is 17.24%. Jade Biosciences has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Jade Biosciences dividend payment date?
The next Jade Biosciences (JBIO) dividend payment date is unconfirmed.
What is the beta indicator for Jade Biosciences?
Jade Biosciences (JBIO) does not currently have a Beta indicator.